Responsible for Information and Publicity Josiane Van der Elst

Slides:



Advertisements
Similar presentations
Groupings: Several Type IA or IA IN affecting one MA One Type IA or change affecting several MAs from the same MAH Tightening of specification limits (change.
Advertisements

Electronic-only submission of FP7 financial statements (forms C) NEXT.
Office Account Procedures for Central Library and GPC Purchases Sheppard Air Force Base Library 82 FSS/FSDL.
EU-PHARE TWINNING PROJECT INTERNATIONAL SEMINAR FROM MUTUAL RECOGNITION TO MUTUAL COMMUNICATION? September 2004 WarsawPresentation of the Polish.
FEDERAL AGENCY FOR MEDICINES AND HEALTH PRODUCTS Federal Agency for Medicines and Health Products (FAMHP) Compassionate Use and Medical Need Program Pharma.be-BeApp,
Federal agency for medicines and health products EXCIPIENTS IN THE LABLE AND PACKAGE LEAFLET OF HOMEOPATHIC MEDICINAL PRODUCTS Patricia Bodart – 23 October.
Extraordinary General Shareholders’ Meeting Brussels, 13 April 2011.
© 2005 Food Supplements Guidance Note Dr. Muireann Cullen Technical Executive
1 Army Policy and Procedures for Proper Use of Non-DoD Contracts Ed Cornett Procurement Policy and Support July 13 & 19, 2005 Presented to: Army Requiring.
S3: Module D Physikalisch-Technische Bundesanstalt Session 3: Conformity Assessment Module D Peter Ulbig, Harry Stolz Belgrade, 31 October.
Registration in lebanon
Standards experts. Accreditation solutions. Andrea Spencer Coordinator, WTO/NAFTA Enquiry Point (Canada) TBT Special Meeting on Procedures for Information.
Requirements of EU pharmacovigilance legislation for distributors Julia Sipos Quality Management Director Pharmacovigilance coordinator Version 03.
Foreigner as a healthcare professional in the territory of Slovak Republic in the context of the Directive of the European Parliament and of the Council.
1 INTERREG IIIB “ATLANTIC AREA” Main points of community regulation 438/2001 financial management and control systems EUROPEAN COMMISSION SPAIN.
Unit 2 Regulations and legal framework of ECTS introduction in Russian Federation.
Erica Cummings Grant Coordinator 1.  The New Mexico Department of Homeland Security and Emergency Management (DHSEM) is responsible for:  Monitoring.
ROMANIA MINISTRY OF HEALTH GENERAL HUMAN RESOURCES DIRECTORATE AND CERTIFICATION ROMANIA MINISTRY OF HEALTH GENERAL HUMAN RESOURCES DIRECTORATE AND CERTIFICATION.
InAHQ Annual Education Meeting Indianapolis, Indiana April 29, 2010
NEW NAMIBIA MEDICINES CONTROL ACT SAPRAA meeting 5 September 2008 Presented by: Johannes Gaeseb Registrar of Medicines NAMIBIA.
Developing Plans and Procedures
Meeting for EU Generic Manufacturers and EU MA holders for generic medicines, Copenhagen, 26 November 2009 Generics approved by stringent regulatory authorities:
7th Framework Programme 2007 – 2013 How to register your organisation for FP7 in URF.
An Overview of Time, Effort, and Resources Needs in the implementation of Public Law The Child Nutrition and WIC Reauthorization Act of 2004.
Federal agency for medicines and health products EC REGULATION 1901/2006 ON MEDICINAL PRODUCTS FOR PAEDIATRIC USE AND HOMEOPATHIC MEDICINAL PRODUCTS Marie-Anne.
Ivowen Ltd1 Ivowen Limited Preparation and Submission of a Traditional Herbal Medicinal Product Application.
Energy Georgi Simeonov European Commission DG ENER, Radiation Protection Unit (D3) Justificação e Optimização das Exposições Médicas a Radiações Ionizantes.
The EU Directive on "Services in the internal market", COM(2004) 2 final/3 Agnese Knabe Project coordinator European Public Health Alliance Civic Alliance.
International conference Quality of Active Pharmaceutical Ingredients Hyderabad, September 2009 API Inspections: the EDQM experience – 7 September.
Indian Health Service Grants Management Grants 101- Fundamentals.
Evaluation of restrictions: art. 15 and art TAIEX Seminar on the EU Service Directive, 3 May 2007 Carlos Almaraz.
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 14 –Transport policy Bilateral screening:
CLAUDIA PANAIT TAIEX Expert – European Commission Legal Adviser Ministry of Health, ROMANIA.
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 6 – Company Law Bilateral screening:
Ministry of Health Department for Nurses and Midwives Belgrade, January 2013 How to create and deliver a curriculum to comply with EU? Bridging.
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 3 – Right of establishment and freedom.
THE OFFICE FOR REGISTRATION OF MEDICINAL PRODUCTS, MEDICAL DEVICES AND BIOCIDAL PRODUCTS Responsibility in the handling of medical devices.
Introduction to the CPR. Transition from CPD to CPR, key dates TAIEX Workshop INT MARKET CPR and CE marking, Baku, 23 and 24 February 2015.
Responsible for Information and Publicity Josiane Van der Elst
Contingent Workforce: Cerner Quality System & Regulations
visit : – Existing User Login
Validation of legal entities and financial capacity check
The Basics of Intellectual Property Reporting
The Citizen in the centre in EU, Bratislava November,2005
Transnational training seminar for potential Lead Partners and Partners to INTEREGG IIIB-CADSES procedures for 3° call for proposal CADSES implementation.
Self-Study Instrument for Early Childhood Centers EDITION
Speedy Assessment of Vaccines: EMA’s toolbox
PAEDIATRIC REGULATION
Overview of Vaccine Landscape in Belgium
MAINTAINING THE INVESTIGATOR’S SITE FILE
PRESENTATION OF MONTENEGRO
Hospice CTI Best Practice.
Market Surveillance Body
Privacy Notice - Requirements
TAIEX, Istanbul, April 19th, 2011
“Responsible for Information and Publicity”
The Mutual Recognition Regulation
Belgian Labour Law New Measures on Labour Law
Regional Seminar for OIE National Focal Points on Animal Production Food Safety Importance of collaboration between the Veterinary Services and industry.
Royal Mail Group: Publishing Volume Commitment Incentive.
Colorado state university-pueblo policy and administration (PA)
Royal Mail Group: Publishing Volume Commitment Incentive.
“Homologation Procedures & Type Approval
Technical Assistance for Development of a Strategy for Alignment with
MAINTAINING THE INVESTIGATOR’S STUDY FILE
Changing the Reference Member State (RMS)
EU Food Safety Requirements: - Hygiene of Foodstuffs -
Royal Mail Group: Publishing Volume Commitment Incentive.
Validation of legal entities and financial viability check
PHARMACOVIGILANCE SYSTEM
Presentation transcript:

Responsible for Information and Publicity Josiane Van der Elst Director General Inspection BRAS meeting 9th of December 2014

Table of contents Legal Context 2. Obligation of the Marketing Autorisation Holder 3. Functions and duties of the Responsible for Information and Publicity 4. Granting of an agreement number as RIP

1. Legal Context The Directive 2001/83/EC of the European Parliament and of the Council of 6/11/2001 on the Community Code relating to Medicinal Products For Human Use, article 98. The Law on the medicinal products of 25/03/1964, article 9. The Royal Decree related to the information and advertising for human use medicinal products of 07/04/1995, articles 11, 13, 14, 15, 17 & 18.

2. Obligation of the MAH (1) The Marketing Authorisation Holder must appoint a person responsible for information and publicity (RIP). The MAH must communicate the name of the RIP to the FAMHP (he can be member of the company or a consultant). Any change must be notified to the FAMHP When the RIP is absent (illness, vacation,…), his replacement must be notified to the FAMHP. Only ONE RIP by MAH.

2. Obligation of the MAH (2) The assignment of a Responsible for Information and Publicity must be sent by postal mail to Nicolas Culquin(Nicolas.culquin@fagg-afmps.be) Federal Agency for Medicines and Health Products  EUROSTATION building, block 2  place Victor Horta, 40/ 40  1060 Brussels In this letter to the FAMHP the company must communicate the name, agreement number and start date of the RIP. This statement must be signed by the General Manager of the MAH and the assigned RIP.

3. Functions and duties of the Responsible for Information and Publicity (1) Responsibilities of the RIP include: Verification of the compliance of the SPC, the leaflets and their translations Must sign the « Declaration of Conformity » for registration of variations on a marketing authorization (OZB 469). Gives final approval on advertising projects Oversees the training of medicinal representatives who visit doctors, pharmacists and other healthcare professionals.

3. Functions and duties of the Responsible for Information and Publicity (2) Ensures compliances of regulations on « samples » (RD 11/01/1993 on fixing the conditions in which the delivery of medicines for human use in the form of samples can be made) Establishes an appropriate internal procedure for approving advertising and various promotional activities Responsible for the information provided by his company ( ex.: questions from patients, professionals,…) Ensures compliance of regulations on « premiums or advantages » (RD 07/04/1995 on the information and publicity concerning human medicines, articles13 § 4, 15 and Law of 25/03/1964 on Medicines, article 10)

4. Granting of an agreement number as RIP (1) 9/12/2014 4. Granting of an agreement number as RIP (1) Conditions: Holder of a legal diploma of pharmacist, doctor or veterinarian The EC nationals, holders of an equivalent diploma can also be approved as RIP with a EU/EEA recognition of his professional title. The Request for recognition EU/EEA professional title must be obtained from the Unit of International Mobility of Healthcare Professionals, FPS Public Health, Directorate General Primary Healthcare and Crisis Management. Justification of an experience of at least one year in the field of the pharmaceutical information (veterinarians: 5 years before 29/08/1984 – RD 07/04/1995, article 13)

4. Granting of an agreement number as RIP (2) The file to be introduced must contain the following documents: A personal request Curriculum Vitae A copy of the diploma of pharmacist, doctor or veterinarian A justification of at least one year of experience in the field of the pharmaceutical information by the presentation of descriptive certificate of the accomplished tasks. This certificate is delivered by the General Manager of the company in which this experience was acquired or a RIP who has an agreement number since more than one year.

4. Granting of an agreement number as RIP (3) All these documents (including personal request) have to be sent by postal mail to the following address : (Publicity@fagg-afmps.be) Federal Agency for Medicines and Health Products  EUROSTATION building, block 2  place Victor Horta, 40/ 40  1060 Brussels Personal contact details (address, phone number, email) are required.

4. Granting of an agreement number as RIP (4) 9/12/2014 4. Granting of an agreement number as RIP (4) If the conditions are fulfilled: An agreement number is communicated by post to the personal address of the applicant. The agreement is published in the Belgian Monitor (annual publication) The agreement number is personal. It is not linked to a company. A RIP can work for different companies. The agreement number is valid during the career of the person except when this person is the object of a procedure of suspension or of withdrawal of his agreement.

Central point of contact RIP Federal agency for medicines and health products - famhp Place Victor Horta 40/40 1060 Bruxelles tel. 0032 2 528 40 00 fax 0032 2 528 40 01 Central point of contact RIP Publicity@afmps.be www.afmps.be